Effects of long-term treatment with α-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for Type 2 diabetes
- 1 September 1999
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 15 (5) , 332-337
Abstract
Continuous hyperglycemia is implicated in the pathogenesis of chronic diabetic complications. It is not well known, however, how and to what extent the development of neuropathy is inhibited by blood glucose control in subjects with Type 2 diabetes. We investigated therefore the effects of an α-glucosidase inhibitor (voglibose; Vg) on neuropathic changes in diabetic Goto-Kakizaki (GK) rats, a genetic model for Type 2 diabetes. Twelve week-old male GK rats were given a diet containing Vg (50 ppm) for 24 weeks and monitored for blood glucose, glycated hemoglobin, motor nerve conduction velocity (MNCV). At the end of the administration period (Na+, K+)-ATPase activity and the structure of the peripheral nerves were examined. Age- and sex-matched normal Wistar rats were treated similarly and served as controls. GK rats showed fasting hyperglycemia after 8 weeks of age, and Vg treatment significantly lowered levels of blood glucose and glycated hemoglobin. Slowing of MNCV to 80% of normal control levels was detected in GK rats. Vg treatment inhibited this delay by 24% at 24 weeks and 57% at 36 weeks of age. Nerve (Na+, K+)-ATPase activity was reduced to 80% of normal control levels in GK rats and was restored by Vg treatment. Teased fiber studies revealed a higher incidence of fibers with paranodal, segmental demyelination and axonal degeneration in GK rats. Vg treatment significantly inhibited the development of these nerve-fiber abnormalities. Lowering of high blood glucose levels achieved by the use of Vg in GK rats improved MNCV and demyelinative nerve changes with restoration of (Na+, K+)-ATPase activity. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Natural History of Peripheral Neuropathy in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- α‐Glucosidase inhibitors in diabetes: lessons from animal studiesEuropean Journal of Clinical Investigation, 1994
- α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjectsEuropean Journal of Clinical Investigation, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of theDiabetes Research and Clinical Practice, 1993
- Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-ratDiabetologia, 1992
- The Effect of Chronic α-Glycosidase Inhibition on Diabetic Nephropathy in the db/db MouseDiabetes, 1982
- Spontaneous Diabetes Produced by Selective Breeding of Normal Wistar RatsProceedings of the Japan Academy, 1975